Mithra Pharmaceuticals SA

ENXTBR:MITRA 株式レポート

時価総額:€12.1m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Mithra Pharmaceuticals 将来の成長

Future 基準チェック /56

Mithra Pharmaceuticals収益と収益がそれぞれ年間100.7%と43.1%増加すると予測されています。

主要情報

100.7%

収益成長率

n/a

EPS成長率

Pharmaceuticals 収益成長15.8%
収益成長率43.1%
将来の株主資本利益率n/a
アナリストカバレッジ

Low

最終更新日06 May 2024

今後の成長に関する最新情報

Recent updates

Not Many Are Piling Into Mithra Pharmaceuticals SA (EBR:MITRA) Stock Yet As It Plummets 26%

Apr 06
Not Many Are Piling Into Mithra Pharmaceuticals SA (EBR:MITRA) Stock Yet As It Plummets 26%

Revenues Working Against Mithra Pharmaceuticals SA's (EBR:MITRA) Share Price Following 39% Dive

Feb 07
Revenues Working Against Mithra Pharmaceuticals SA's (EBR:MITRA) Share Price Following 39% Dive

Party Time: Brokers Just Made Major Increases To Their Mithra Pharmaceuticals SA (EBR:MITRA) Earnings Forecasts

Nov 09
Party Time: Brokers Just Made Major Increases To Their Mithra Pharmaceuticals SA (EBR:MITRA) Earnings Forecasts

These Analysts Just Made A Huge Downgrade To Their Mithra Pharmaceuticals SA (EBR:MITRA) EPS Forecasts

Oct 05
These Analysts Just Made A Huge Downgrade To Their Mithra Pharmaceuticals SA (EBR:MITRA) EPS Forecasts

Take Care Before Diving Into The Deep End On Mithra Pharmaceuticals SA (EBR:MITRA)

May 23
Take Care Before Diving Into The Deep End On Mithra Pharmaceuticals SA (EBR:MITRA)

Bullish: Analysts Just Made A Huge Upgrade To Their Mithra Pharmaceuticals SA (EBR:MITRA) Forecasts

Aug 11
Bullish: Analysts Just Made A Huge Upgrade To Their Mithra Pharmaceuticals SA (EBR:MITRA) Forecasts

Growth Investors: Industry Analysts Just Upgraded Their Mithra Pharmaceuticals SA (EBR:MITRA) Revenue Forecasts By 21%

Mar 13
Growth Investors: Industry Analysts Just Upgraded Their Mithra Pharmaceuticals SA (EBR:MITRA) Revenue Forecasts By 21%

Mithra Pharmaceuticals (EBR:MITRA) Is Making Moderate Use Of Debt

Dec 22
Mithra Pharmaceuticals (EBR:MITRA) Is Making Moderate Use Of Debt

Some Mithra Pharmaceuticals SA (EBR:MITRA) Analysts Just Made A Major Cut To Next Year's Estimates

Nov 24
Some Mithra Pharmaceuticals SA (EBR:MITRA) Analysts Just Made A Major Cut To Next Year's Estimates

Here's Why Mithra Pharmaceuticals (EBR:MITRA) Can Afford Some Debt

Jun 07
Here's Why Mithra Pharmaceuticals (EBR:MITRA) Can Afford Some Debt

When Will Mithra Pharmaceuticals SA (EBR:MITRA) Turn A Profit?

May 10
When Will Mithra Pharmaceuticals SA (EBR:MITRA) Turn A Profit?

Is Mithra Pharmaceuticals SA's (EBR:MITRA) Shareholder Ownership Skewed Towards Insiders?

Mar 18
Is Mithra Pharmaceuticals SA's (EBR:MITRA) Shareholder Ownership Skewed Towards Insiders?

We're Not So Sure You Should Rely on Mithra Pharmaceuticals' (EBR:MITRA) Statutory Earnings

Feb 16
We're Not So Sure You Should Rely on Mithra Pharmaceuticals' (EBR:MITRA) Statutory Earnings

Analysts Expect Breakeven For Mithra Pharmaceuticals SA (EBR:MITRA) Before Long

Jan 21
Analysts Expect Breakeven For Mithra Pharmaceuticals SA (EBR:MITRA) Before Long

Some Mithra Pharmaceuticals SA (EBR:MITRA) Analysts Just Made A Major Cut To Next Year's Estimates

Nov 29
Some Mithra Pharmaceuticals SA (EBR:MITRA) Analysts Just Made A Major Cut To Next Year's Estimates

業績と収益の成長予測

ENXTBR:MITRA - アナリストの将来予測と過去の財務データ ( )EUR Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
12/31/202613744N/AN/A1
12/31/20259614N/AN/A1
12/31/202444-55N/AN/A1
12/31/202340-174-2-2N/A
9/30/202351-126-15-6N/A
6/30/202363-79-28-9N/A
3/31/202365-69-55-33N/A
12/31/202267-60-82-57N/A
9/30/202244-76-92-68N/A
6/30/202222-93-102-78N/A
3/31/202222-105-100-78N/A
12/31/202123-117-98-77N/A
9/30/202121-115-94-75N/A
6/30/202119-113-91-73N/A
3/31/202114-103-94-77N/A
12/31/20209-92-96-80N/A
9/30/202044-31-85-70N/A
6/30/20207929-73-59N/A
3/31/2020881-68-53N/A
12/31/201997-27-62-47N/A
9/30/201984-54-42-28N/A
6/30/201971-82-21-5N/A
3/31/201964-55-14-1N/A
12/31/201858-28-74N/A
9/30/201846-41-23-9N/A
6/30/201833-53-40-25N/A
3/31/201833-46-44-28N/A
12/31/201732-38-47-31N/A
9/30/201726-37N/A-32N/A
6/30/201720-36N/A-32N/A
3/31/201721-36N/A-28N/A
12/31/201622-35N/A-23N/A
9/30/201621-29N/A-23N/A
6/30/201620-23N/A-22N/A
3/31/201620-16N/A-20N/A
12/31/201520-10N/A-18N/A
9/30/201519-9N/A-15N/A
6/30/201518-8N/A-12N/A
3/31/201519-5N/A-6N/A
12/31/201419-3N/A-1N/A
12/31/201318-2N/A1N/A

アナリストによる今後の成長予測

収入対貯蓄率: MITRAは今後 3 年間で収益性が向上すると予測されており、これは 貯蓄率 ( 1.3% ) よりも高い成長率であると考えられます。

収益対市場: MITRA今後 3 年間で収益性が向上すると予想されており、これは市場平均を上回る成長と考えられます。

高成長収益: MITRA今後 3 年以内に収益を上げることが予想されます。

収益対市場: MITRAの収益 ( 43.1% ) Belgian市場 ( 7.1% ) よりも速いペースで成長すると予測されています。

高い収益成長: MITRAの収益 ( 43.1% ) 20%よりも速いペースで成長すると予測されています。


一株当たり利益成長率予想


将来の株主資本利益率

将来のROE: MITRAの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です


成長企業の発掘